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~ Quantitative Oobul~mlne~ Stress Echocardiography 
Utilizing Doppler Tissue Imaging 
Hector L Fontanet, John A. PuteO, Mifct~ll G. Davis, Ma~ Lockeby, 
Use Thannlkary, OOU91as D, Scho~en. DMsion of Cardiology, University. of 
South Florida, Tampa, F~or~da 
Detection of myoo,.~diai ischemla (MIS) by Dobutemine Stress Echo (DSE) 
is limited by qualitative, observer dependent Shah/sis Doppler tissue imegt~g 
(DTI) (Acuson XPc 128) can measure myocardial velocities during DSE and 
may be useful to quantify wall motion abnormalities. Themtom, the purpose 
of this study Is to c~temline whether pulsed wave DTI can detect and quantity 
stress Induced MIS by changes in MV. Methods: 24 i~tle~ts had DSE with 
DTI. Systolic velociflcs (SV) of the loferior(IW) and antedo~' walls(AWl were 
examined. 16 patients had a normal response and 8 had inducible Ischemla. 
The abnormal group had arlgiogt~aphlc evidence of coronary disease (C~Et) 
(RCA or LAD > 70%). Results: There was a signglcant dose depand~nt 
increase in SV in the normal group: tW 0.064 to 0.133 m/s (p < 0,0001); AW 
0.05-,0.10 r~s (p < 0.001). Compared to normats, patients with CAD had 
lower resting SV and a blunted increase during DSE: IW 0.043 to 0.069 m/s 
(p < 0,0001); AW 0,04-0,06 m/s (p < 0,01) (figure). 
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Co~[~sions: Patients with CAD have impaired augmontatlon of systolic 
myocardial velocities during DSE. Thus, DTI may be useful in the quantitative 
anaiysis of slreSS induced myocarolai ischemla. 
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~ A  Ho,,ml inhibitor of Plssm|ne~ert Acttvato~ 
inhibltsr-1, T-686, Modulates Development of 
Atherosclerosls in Vlvo In Rabbits 
Beds VInegradsky, Stephen P, Bell, Hitoshi Okada, Amy S, Guaia, 
DagnijaThomton, Satosh~ FuJit, Washington Unh, arsily, St. Lou;s, Me; 
University of Vermont, Burlington, VT 
We have previously shown that plasmlnegen activator inhibitor-1 (PAl-I), 
the major inhibitor of tissue-type plasmlnogan astivator and urokinase, is 
abundantly expressed in athorosclerotlc vascular wall. To dotsrmine the role 
of PAI-I In vascular wail, we have used a novel inhibitor of PAl-l, (3E, 4E)-3- 
benzyltdene-4-(3,4,5-trlmsthoxy-benzylideno)-pyrrolldlne-2,5-dione ('r-686). 
In rabbits with aDdle atherosslerosls induced by hypercholesterolemia and 
implantation of indwelling plastic tubing, oral administration el T-686 (30 
mg/kg body wc~ght) for 8 weeks attenuated the Increase In Plasma PAl-1 
activity induced by vascular injury (2.7 ± 0.9 (SE) AU/ml, n = 7, vs 4.0 .~ 0.8 
AU/ml In control, n = 8) without altering blood triglycaride and cholesterol. 
Thle was accompanied by the reduction in so,lie PN-1 mRNA expression 
(relative absod:)ance PAI-1/GAR 0.21 • 0.04, n = 7 vs 0.86 ~ 0,20 in control, 
n ,= 8, p .~ 0.05, Northern) and the inhibition of development of athomsderasis 
lesions (lesion area over total addle area, 25:1= 2%, n = 8, vs 44 :t: 7% in 
control, n = 9, p < 0.05). 1"-686 prevented the accumulation of PAl-1 within the 
aortic lesions (Immunohfstoohemistry) and expansion of extmcollular matrix 
(maximal intimai thickness, 124 -4- 10 p.m, n = 8, vs 155 ~: 22 pm in control, n 
,= 9). In contrast, PAF1 mRNA expression in liver was not altered (Northern). 
ThuS, T-686 not only decreased PAl-1 synthesis atsctively in vascular Cells 
but also protected against the development of vascular lesions In rive. This 
compound may be useful in relining the role ol PAt-1 in atherothromt~Otio 
states. 
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Prothrombotlc Fec lom and Edothellal DyMuncl ion 
In Left Ventdcular Hypertrophy: ImpliP.atlons for 
Thrombogenesls and Atherogenesla 
Gregory YH Up, Andrew Blann, Peck Un Lip, Gareth Beavers. University 
Department of Medicine, City Hospital, Birmingham, England 
Hypertensive patients with left ventrlcular hypertrophy (LVH) are at high risk 
of thrombaembOlism and atherogenosis. TO investigate this further, we mea- 
sured p~asma levels of the soluble adhesion melecute P.setsctln (ELISA, 
R&D Systems; assootated v~th platetet adhesion ~.ed alhgrosclerosis), Yon 
Wi~ebra~d factoY ~vWF; ELqSA, OAKO; a marker ot eedofhaiiat dysfunction), 
fibrin D.dimer (AGEN-ELISA; an index of fibrin fumover/thrombo(Janasls), 
plasmlnegen ac~ator Inhlbttor (PAt, an index of tr~aired flbfl~olyais & In. 
creased lhromboganesls) and llbrinngen {PF; CLAUSE;) in 159 patients (74 
male; mean age 54.1 years, e.d. 1¢8) with essential hypertension, in whom 
the left ventricular mass index (LVMI) was determined using echocardiogra- 
phy. Levels were compare~ to 47 normotendve healthy controls (mean age 
55.0 years, s.d. 19.2). 
Results: 
Hypertensive Conlrols 
Mean bicmd pressure (BP) 180/101 133/81 mmHg 
P-sel~ctln (ng/ml) mad/an (IQR) 300 @ (190,480) 212 (160-3500) 
PAt {~g/ml) medlan (~QR) 31.0" |2~.5-43.1) 19.6 (10.9--31.0) 
D-dlmer(nglmi)medlan(IOR) 250" (190,~0) IS8 (100-231) 
vWF (iU/d|} mean (s.d.) 115"* (30} 07 (27,) 
fibrinogen (g/I) mean (s.d.) 3.39 + if.02) 2.9~ (0.49) 
@p = 0.016, *p < e.oool, "*t-test; p = 0,0002, +p - 0,001 
Patients with LVH (defined as LVMI > 134/n~ in males or > 110 g/m ~ in 
females) had higher PF compared to those without LVH (3.51 vs 2.95 g/I; 
p = 0,0006). D-dimer levels were correlated with vWt (Spearman, r = 0.45; 
p < 0,001) and PF (r = 0,20; p = 0.035) levels. PF levels were correlated 
with systolic and diastolic BPs (both r = 0,40; p < 0.001), LVMI (r = 0.23; 
p = 0.018), left atrial size (r = 0,32, p =~ 0,002), P-seleclin (r ,= 0.17; p = 
0,05) e.d vWF {r = 0.34; p< 0,001). This study suggests that hypertensives 
have h4gh PF levels, thmmbagenasis and impaired fibd~otysts ~as indioated 
by high D-direst and PAl levels), plalelet dysfunction (raised P.salectin) and 
endothelial dysfunction (high vWF). The high PF levels were related to ape, 
LVMI (and LVH) and left atrial size. These factors may act synergistically to 
increase the dsk of thmmbogenosis and atherosclerosls and may explain the 
high dsk of vascular disease in hypertensives with LVH. 
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~ R o l e  the Procoagulant Activity on of Factor XaNa in 
Balloon.Injured Artsdes 
Giorgio Ghigliotti 1 Dana R. Abendschain, Christopher M. Spaidel, Paul 
R. Eiset~berg. I Univers~y of Genoa, Italy; Washington University School or 
Medicine St. Louis, MO 
We and others have shown that balloon-induced deep arterial injury exposes 
tissue factor (TF), which initiates thrombosis. However, the contributions of 
th~mbin and XaNa activity elaborated and bound at the site of in|uq/to 
the progression of thrombosis is not known, To determine their relative role, 
deep injury to the abdominal aorta was induced by oveflnt~ation of a 4F 
Fegady calheter tn 29 anesthetized rabbits. As a control group, eight other 
rabbits underwent the surgical procedures, but without balloon ovednflalion. 
Aortae were perfused in situ with phosphate-buffered saline to prevent In- 
travascular cloffing, excised and extensively washed in buffer. Injured ~.ortic 
segments were incubated for 30 rain with reca1¢itied plasma depleted of 
vifamin K-dependent factors by edsorbtion with barium ohPodd9 (Be plasma) 
to characterize thmmbin activity, followed by incubation with Ba plasma con- 
taining 0.9 pM prothrombio to characterize Xa/Va activity. Concentrations of 
tibfinopeptide A (FPA) were measured in the incubat~:l plasma as a marker 
of thrombin-mediated flbdn formation. Uninjured segments did not induce 
significant increases in FPA in =Ja plasma with (26 :E 20 ng/ml, mean 4- SO) 
or without (9 '4- S ng/ml) added prothmmbln. Injured segments also did not 
induce fibrin formation in Ba plasma (19 :t: 13 ng/ml), consistent with little 
